An open-label trial of L-glucose as a colon-cleansing agent before colonoscopy

Gastrointestinal Endoscopy

Volumn 58, Issue 1, 2003, Pages 30-35

  Raymer, Geoffrey S ^a   Hartman, Donald E ^a   Rowe, William A ^a   Werkman, Robert F ^a   Koch, Kenneth L ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAXATIVE; LEVO GLUCOSE; DETERGENT; GLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON LAVAGE; COLONOSCOPY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; FLUID BALANCE; FLUID INTAKE; HEADACHE; HUMAN; MALE; OUTPATIENT CARE; PALATABILITY; PRIORITY JOURNAL; SIDE EFFECT; AMBULATORY CARE; ANALYSIS OF VARIANCE; CONFIDENCE INTERVAL; LAVAGE; METHODOLOGY; MIDDLE AGED; PROBABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AGED; AMBULATORY CARE; ANALYSIS OF VARIANCE; COLONOSCOPY; CONFIDENCE INTERVALS; DETERGENTS; FEMALE; GLUCOSE; HUMANS; IRRIGATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROBABILITY; SENSITIVITY AND SPECIFICITY;

EID: 0346811294     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.293     Document Type: Article

References (16)

1. Clarkston WK, Tsen TN, Dies DF, Schratz L, Vaswani SK, Bjerregaard P. Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison. Gastrointest Endosc 1996;43:42-8.
2. Ahmed M, Raval P, Buganza G. Oral sodium phosphate catharsis and acute renal failure. Am J Gastroenterol 1996;91:1261-2.
3. Adverse Drug Reactions Advisory Committee (ADRAC): electrolyte disturbances with oral phosphate bowel preparations. Australian Adverse Drug Reactions Bulletin 1997;16.
4. Bolvin MA, Kahn SR. Symptomatic hypocalcemia from oral sodium phosphate: a report of 2 cases. Am J Gastroenterol 1998;93:2577-9.
5. Orias M, Mahnensmith RL, Perazella MA. Extreme hyperphosphatemia and acute renal failure after a phosporus-containing bowel regimen. Am J Nephrol 1999;19:60-3.
6. Vukasin P, Weston LA, Beart RW. Oral Fleet phospho-soda laxative induced hyperphosphatemia and hypocalcemic tetany in an adult. Dis Colon Rectum 1997;40:497-9.
7. Ullah N, Yeh R, Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 2002;34:457-8.
8. Turnage RH, Guice KS, Gannon P, Gross M. The effect of polyethylene glycol gavage on plasma volume. J Surg Res 1994;57:284-8.
9. DiPalma JA, Buckley SE, Warner BA, Culpepper RM. Biochemical effects of oral sodium phosphate. Dig Dis Sci 1996;41:749-53.
10. Huyah T, Vanner S, Paterson W. Safety profile of 5-h oral sodium phosphate regimen for colonoscopy cleansing: lack of clinically significant hypocalcemia or hypovolemia. Am J Gastroenterol 1995;90:104-7.
11. Lieberman DA, Ghormley J, Flora K. Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. Gastrointest Endosc 1996;43:467-9.
12. Vanner SJ, MacDonald PH, Paterson WG, Prentice RSA, DaCosta LR, Beck IT. A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (GoLYTELY) in the preparation of patients for colonoscopy. Am J Gastroenterol 1990;85:422-7.
13. Mission Pharmacal Company, San Antonio, TX. Data on file.
14. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Effect of D-glucose on intestinal permeability and its passive absorption in human small intestine in vivo. Gastroenterology 1993;105:1117-25.
15. FDA Summary Basis of Approval; GoLYTELY No. NDA 19-011; NuLYTELY No. NDA 19-797.
16. Kastenberg D, Chasen R, Choudhary C, Riff D, Steinberg S, Weiss E, et al. Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multicenter phase III trials. Gastrointest Endosc 2001;54:705-13.